NCT07287917 2026-03-12
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Aminex Therapeutics, Inc.
Phase 1/2 Recruiting
Aminex Therapeutics, Inc.
University of Chicago
Relay Therapeutics, Inc.
West German Study Group
AstraZeneca